BIOCENTIS S.R.L.

Every year, millions of people die or fall seriously ill from insect-borne diseases — malaria, dengue, chikungunya — while the agricultural sector battles pests that are growing increasingly resistant to conventional chemical pesticides. It is on this two-front challenge that Biocentis, a Milan-based startup, has chosen to focus: not killing insects with toxins, but controlling their proliferation through ecological and sustainable methods. The company's mission has been clear from day one: to revolutionize pest control by eliminating reliance on conventional pesticides, which leave environmental residues, gradually develop resistance, and indiscriminately kill beneficial species such as bees. Biocentis positions its solutions at the intersection of biotechnology and environmental sustainability, developing selective approaches that target only the relevant species without damaging surrounding ecosystems. The business model is structured around B2B relationships: the company develops services and custom solutions for agricultural businesses, public health operators, infrastructure managers, and any organization that needs to manage insect populations in a controlled and verifiable way. This project-based approach allows Biocentis to adapt its technologies to the specific context of each client, from large-scale plantations to government tropical disease control programs. The addressable market is substantial: the global pest control sector is worth billions of dollars annually, under growing pressure from increasingly strict environmental regulations and end-consumer demand for residue-free agricultural products. At the same time, climate change is expanding the geographic range in which vector insects like the tiger mosquito thrive, opening new markets for solutions like those Biocentis is developing. The company's long-term goal is to help build a world where a growing global population can be fed without sacrificing ecosystem health, and where vector-borne diseases are contained without resorting to persistent chemical agents. It is an ambitious vision — one that demands not only scientific rigor, but also the ability to build strong partnerships with public institutions, agro-industrial companies, and international health organizations.